Role of ER-α36 in breast cancer by typical xenoestrogens

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Tumor Biology

• Publication date

  2015-09-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13277-015-4006-xPMID 26337277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

  2015cited by this paper
• Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors

  2015cited by this paper
• Occurrence of Endocrine-Disrupting Phenols and Estrogens in Water and Sediment of the Songhua River, Northeastern China

  2014cited by this paper
• Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation.

  2014cited by this paper
• The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified

  2014cited by this paper
• Role of ERα36 in membrane-associated signaling by estrogen.

  2014cited by this paper
• Estrogen activation of the mitogen-activated protein kinase is mediated by ER-α36 in ER-positive breast cancer cells.

  2014cited by this paper
• GP88 (Progranulin) Confers Fulvestrant (Faslodex, ICI 182,780) Resistance to Human Breast Cancer Cells

  2014cited by this paper
• Known and emerging factors modulating estrogenic effects of endocrine-disrupting chemicals

  2014cited by this paper
• Strategies to Overcome Resistance to Hormonal Therapy

  2014cited by this paper
• A novel anti-cancer agent, acetyltanshinone IIA, inhibits oestrogen receptor positive breast cancer cell growth by down-regulating the oestrogen receptor.

  2014cited by this paper
• Predictive and prognostic value of ER-α36 expression in breast cancer patients treated with chemotherapy.

  2014cited by this paper
• Estrogen Receptor-α36 Is Involved in Pterostilbene-Induced Apoptosis and Anti-Proliferation in In Vitro and In Vivo Breast Cancer

  2014cited by this paper
• Bisphenol A--sources, toxicity and biotransformation.

  2014cited by this paper
• Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERα expression and induction of apoptosis

  2014cited by this paper
• A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.

  2014cited by this paper
• 17Beta-Estradiol Promotes Aggressive Laryngeal Cancer Through Membrane-Associated Estrogen Receptor-Alpha 36

  2014cited by this paper
• T47D breast cancer cells switch from ER/HER to HER/c-Src signaling upon acquiring resistance to the antiestrogen fulvestrant.

  2014cited by this paper
• An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism

  2013cited by this paper
• A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)-α36 expression and inhibits growth of ER-negative breast cancer MDA-MB-231 cells.

  2013cited by this paper
• Estrogen receptor‐α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells

  2013cited by this paper
• Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity.

  2013cited by this paper
• Alternate Estrogen Receptors Promote Invasion of Inflammatory Breast Cancer Cells via Non-Genomic Signaling

  2012cited by this paper
• Intracellular and plasma membrane-initiated pathways involved in the [Ca2+]i elevations induced by iodothyronines (T3 and T2) in pituitary GH3 cells.

  2012cited by this paper
• Estrogen-independent effects of ER-α36 in ER-negative breast cancer.

  2012cited by this paper
• Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells.

  2012cited by this paper
• Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells

  2012cited by this paper
• Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-α36 (ERα36)*

  2012cited by this paper
• Advances in the understanding of the structure and function of ER-α36,a novel variant of human estrogen receptor-alpha.

  2011cited by this paper
• A positive cross-regulation of HER2 and ER-α36 controls ALDH1 positive breast cancer cells.

  2011cited by this paper
• The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma Membrane

  2011cited by this paper
• ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK Pathway

  2010cited by this paper
• Combinations of Physiologic Estrogens with Xenoestrogens Alter ERK Phosphorylation Profiles in Rat Pituitary Cells

  2010cited by this paper
• Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.

  2010cited by this paper
• ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways

  2010cited by this paper
• A Positive Feedback Loop of ER-α36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells

  2010cited by this paper
• ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast

  2010cited by this paper
• Expression of ER- 36, a Novel Variant of Estrogen Receptor , and Resistance to Tamoxifen Treatment in Breast Cancer

  2009cited by this paper
• Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.

  2009cited by this paper
• Low Doses of Bisphenol A Promote Human Seminoma Cell Proliferation by Activating PKA and PKG via a Membrane G-Protein–Coupled Estrogen Receptor

  2009cited by this paper
• Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-α36

  2009cited by this paper
• Estrogen receptor‐alpha (ER‐α) suppresses expression of its variant ER‐α36

  2009cited by this paper
• Mitogen‐activated protein kinase (MAPK) pathway mediates the oestrogen‐like activities of ginsenoside Rg1 in human breast cancer (MCF‐7) cells

  2009cited by this paper
• Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells.

  2008cited by this paper
• Integrating signals between cAMP and MAPK pathways in breast cancer.

  2008cited by this paper
• ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas.

  2008cited by this paper
• ER-α36, a Novel Variant of ER-α, is Expressed in ER-positive and -negative Human Breast Carcinomas

  2008cited by this paper
• Protein kinase C delta enhances proliferation and survival of murine mammary cells.

  2007cited by this paper
• Protein kinase C δ enhances proliferation and survival of murine mammary cells

  2007cited by this paper
• The Crucial Role of Cyclooxygenase-2 in Osteopontin-Induced Protein Kinase C α/c-Src/IκB Kinase α/β–Dependent Prostate Tumor Progression and Angiogenesis

  2006cited by this paper
• Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.

  2006cited by this paper
• The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis.

  2006cited by this paper
• Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours

  2006cited by this paper
• Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells.

  2006cited by this paper
• A variant of estrogen receptor-α, hER-α36: Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling

  2006cited by this paper
• A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.

  2006cited by this paper
• Advances in the treatment of endometrial cancer

  2005cited by this paper
• Estrogenic effects of two derivatives of icariin on human breast cancer MCF-7 cells.

  2005cited by this paper
• PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling.

  2005cited by this paper
• Identification, cloning, and expression of human estrogen receptor-α36, a novel variant of human estrogen receptor-α66

  2005cited by this paper
• Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.

  2005cited by this paper
• Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66.

  2005cited by this paper
• BRCA1 Inhibits Membrane Estrogen and Growth Factor Receptor Signaling to Cell Proliferation in Breast Cancer

  2004cited by this paper
• Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

  2004cited by this paper
• Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.

  2003cited by this paper
• The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles.

  2003cited by this paper
• Proximal Events in Signaling by Plasma Membrane Estrogen Receptors*

  2003cited by this paper
• Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells.

  2002cited by this paper
• ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR.

  2001cited by this paper
• Estrogen receptors and proliferation markers in primary and recurrent breast cancer

  2001cited by this paper
• Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells

  2001cited by this paper
• Akt activation by estrogen in estrogen receptor-negative breast cancer cells.

  2001cited by this paper
• Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo.

  1998cited by this paper
• Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7.

  1997cited by this paper
• Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer.

  1997cited by this paper
• Responses to Pure Antiestrogens (ICI 164384, ICI182780) in Estrogen‐Sensitive and‐Resistant Experimental and Clinical Breast Cancer a

  1995cited by this paper
• Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription.

  1994cited by this paper
• Functional domains of the human estrogen receptor.

  1987cited by this paper
• Reproductive Biology and Endocrinology Open Access a Novel Variant of Er-alpha, Er-alpha36 Mediates Testosterone-stimulated Erk and Akt Activation in Endometrial Cancer Hec1a Cells

  year unknowncited by this paper

• Prognostic significance of combined serum immunological HER2 and ERα36 biomarkers in estrogen receptor-positive breast cancer subtypes.

  2025cites this paper
• Impact of xenoestrogens on sex differentiation and reproduction in teleosts

  2022cites this paper
• 17β-Estradiol Promotes Apoptosis of HepG2 Cells Caused by Oxidative Stress by Increasing Foxo3a Phosphorylation

  2021cites this paper
• Low concentrations of 17β‐estradiol exacerbate tamoxifen resistance in breast cancer treatment through membrane estrogen receptor‐mediated signaling pathways

  2021cites this paper
• The effects of estradiol on inflammatory and endothelial dysfunction in rats with preeclampsia

  2020cites this paper
• Quercetin exerts bidirectional regulation effects on the efficacy of tamoxifen in estrogen receptor‐positive breast cancer therapy: An in vitro study

  2020cites this paper
• 17β‐Estradiol inhibits testosterone‐induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor

  2018cites this paper
• Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.

  2018cites this paper
• The role of sex hormones and steroid receptors on female reproductive cancers.

  2017influential citation
• Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex

  2017cites this paper
• GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer

  2017cites this paper
• Breast Cancer Progression and Phytoestrogen Interactions with Estrogen Receptors

  2017cites this paper
• Communication between genomic and non‐genomic signaling events coordinate steroid hormone actions

  2017cites this paper
• Known and emerging factors modulating estrogenic effects of endocrine-disrupting chemicals

  2014cites this paper